Leukocyte diversity in resolving and nonresolving mechanisms of cardiac remodeling

FASEB Journal

Volumn 31, Issue 10, 2017, Pages 4226-4239

  Tourki, Bochra ^a   Halade, Ganesh ^b  

^a UNIVERSITY OF CARTHAGE   (Tunisia)

^b University of Alabama at Birmingham and Birmingham Veterans Affairs Medical Center   (United States)

Author keywords

Heart failure; Inflammation; Myocardial infarction; Resolution of inflammation

Indexed keywords

AGING; CELL DENSITY; CELL KINETICS; DIABETES MELLITUS; GENETIC VARIABILITY; HEART FAILURE; HEART INFARCTION; HEART MUSCLE INJURY; HEART VENTRICLE REMODELING; HUMAN; HYPERTENSION; IMMUNOCOMPETENT CELL; LEUKOCYTE; LYMPHOCYTE; MACROPHAGE; MICROENVIRONMENT; MONOCYTE; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; NEUTROPHIL; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; ANIMAL; CARDIAC MUSCLE CELL; INFLAMMATION; METABOLISM; PHYSIOLOGY;

ANIMALS; HUMANS; INFLAMMATION; LEUKOCYTES; MACROPHAGES; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; VENTRICULAR REMODELING;

EID: 85028530849     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.201700109R     Document Type: Review

References (141)

1. Frangogiannis, N. G. (2012) Regulation of the inflammatory response in cardiac repair. Circ. Res. 110, 159–173
2. Cochain, C., Auvynet, C., Poupel, L., Vilar, J., Dumeau, E., Richart, A., Récalde, A., Zouggari, Y., Yin, K. Y. H. W., Bruneval, P., Renault, G., Marchiol, C., Bonnin, P., Lévy, B., Bonecchi, R., Locati, M., Combadière, C., and Silvestre, J.-S. (2012) The chemokine decoy receptor D6 prevents excessive inflammation and adverse ventricular remodeling after myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 32, 2206–2213
3. Serhan, C. N., Brain, S. D., Buckley, C. D., Gilroy, D. W., Haslett, C., O’Neill, L. A. J., Perretti, M., Rossi, A. G., and Wallace, J. L. (2007) Resolution of inflammation: state of the art, definitions and terms. FASEB J. 21, 325–332
4. Horckmans, M., Ring, L., Duchene, J., Santovito, D., Schloss, M. J., Drechsler, M., Weber, C., Soehnlein, O., and Steffens, S. (2017) Neutrophils orchestrate post-myocardial infarction healing by polarizing macrophages towards a reparative phenotype. Eur. Heart J. 38, 187–197
5. Van Dyke, T. E., and Kornman, K. S. (2008) Inflammation and factors that may regulate inflammatory response. J. Periodontol. 79 (8 Suppl), 1503–1507
6. Kain, V., Prabhu, S. D., and Halade, G. V. (2014) Inflammation revisited: inflammation versus resolution of inflammation following myocardial infarction. Basic Res. Cardiol. 109, 444
7. Freire, M. O., and Van Dyke, T. E. (2013) Natural resolution of inflammation. Periodontol. 2000 63, 149–164
8. Lucchesi, B. R., Werns, S. W., and Fantone, J. C. (1989) The role of the neutrophil and free radicals in ischemic myocardial injury. J. Mol. Cell. Cardiol. 21, 1241–1251
9. Dutta, P., and Nahrendorf, M. (2015) Monocytes in myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 35, 1066–1070
10. Ortega-Gómez, A., Perretti, M., and Soehnlein, O. (2013) Resolution of inflammation: an integrated view. EMBO Mol. Med. 5, 661–674
11. Neely, C. J., Kartchner, L. B., Mendoza, A. E., Linz, B. M., Frelinger, J. A., Wolfgang, M. C., Maile, R., and Cairns, B. A. (2014) Flagellin treatment prevents increased susceptibility to systemic bacterial infection after injury by inhibiting anti-inflammatory IL-10+ IL-12neutrophil polarization. PLoS One 9, e85623
12. Amantea, D. (2016) Polarizing the immune system towards neuroprotection in brain ischemia. Neural Regen. Res. 11, 81–82
13. Ma, Y., Yabluchanskiy, A., Iyer, R. P., Cannon, P. L., Flynn, E. R., Jung, M., Henry, J., Cates, C. A., Deleon-Pennell, K. Y., and Lindsey, M. L. (2016) Temporal neutrophil polarization following myocardial infarction. Cardiovasc. Res. 110, 51–61
14. Ma, Y., Yabluchanskiy, A., and Lindsey, M. L. (2013) Neutrophil roles in left ventricular remodeling following myocardial infarction. Fibrogenesis Tissue Repair 6, 11
15. Iyer, R. P., Patterson, N. L., Zouein, F. A., Ma, Y., Dive, V., de Castro Brás, L. E., and Lindsey, M. L. (2015) Early matrix metalloproteinase-12 inhibition worsens post-myocardial infarction cardiac dysfunction by delaying inflammation resolution. Int. J. Cardiol. 185, 198–208
16. Prince, L. R., Whyte, M. K., Sabroe, I., and Parker, L. C. (2011) The role of TLRs in neutrophil activation. Curr. Opin. Pharmacol. 11, 397–403
17. De Haan, J. J., Smeets, M. B., Pasterkamp, G., and Arslan, F. (2013) Danger signals in the initiation of the inflammatory response after myocardial infarction. Mediators Inflamm. 2013, 206039
18. Lopez, E. F., Kabarowski, J. H., Ingle, K. A., Kain, V., Barnes, S., Crossman, D. K., Lindsey, M. L., and Halade, G. V. (2015) Obesity superimposed on aging magnifies inflammation and delays the resolving response after myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 308, H269–H280
19. Ross, E. A., Douglas, M. R., Wong, S. H., Ross, E. J., Curnow, S. J., Nash, G. B., Rainger, E., Scheel-Toellner, D., Lord, J. M., Salmon, M., and Buckley, C. D. (2006) Interaction between integrin alpha9beta1 and vascular cell adhesion molecule-1 (VCAM-1) inhibits neutrophil apoptosis. Blood 107, 1178–1183
20. Mehta, J., Dinerman, J., Mehta, P., Saldeen, T. G., Lawson, D., Donnelly, W. H., and Wallin, R. (1989) Neutrophil function in ischemic heart disease. Circulation 79, 549–556
21. Vinten-Johansen, J. (2004) Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc. Res. 61, 481–497
22. Tanaka, M., Brooks, S. E., Richard, V. J., FitzHarris, G. P., Stoler, R. C., Jennings, R. B., Arfors, K. E., and Reimer, K. A. (1993) Effect of anti-CD18 antibody on myocardial neutrophil accumulation and infarct size after ischemia and reperfusion in dogs. Circulation 87, 526–535
23. Faxon, D. P., Gibbons, R. J., Chronos, N. A. F., Gurbel, P. A., and Sheehan, F.; HALT-MI Investigators. (2002) The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study. J. Am. Coll. Cardiol. 40, 1199–1204
24. Granger, D. N., and Schmid-Schönbein, G. W. (1995) Physiology and Pathophysiology of Leukocyte Adhesion, Oxford University Press, New York
25. Heilker, R., Wolff, M., Tautermann, C. S., and Bieler, M. (2009) G-protein-coupled receptor-focused drug discovery using a target class platform approach. Drug Discov. Today 14, 231–240
26. Peart, J. N., and Headrick, J. P. (2007) Adenosinergic cardioprotection: multiple receptors, multiple pathways. Pharmacol. Ther. 114, 208–221
27. Koeppen, M., Harter, P. N., Bonney, S., Bonney, M., Reithel, S., Zachskorn, C., Mittelbronn, M., and Eckle, T. (2012) Adora2b signaling on bone marrow derived cells dampens myocardial ischemia-reperfusion injury. Anesthesiology 116, 1245–1257
28. Fleming, S. D., Mastellos, D., Karpel-Massler, G., Shea-Donohue, T., Lambris, J. D., and Tsokos, G. C. (2003) C5a causes limited, polymorphonuclear cell-independent, mesenteric ischemia/ reperfusion-induced injury. Clin. Immunol. 108, 263–273
29. Stahl, G. L., Xu, Y., Hao, L., Miller, M., Buras, J. A., Fung, M., and Zhao, H. (2003) Role for the alternative complement pathway in ischemia/reperfusion injury. Am. J. Pathol. 162, 449–455
30. Lin G. M., Li Y. H., Jaiteh L. E., and Han C. L. (2012) Pexelizumab fails to inhibit assembly of the terminal complement complex in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Insight from a substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. Am. Heart J. 164, e19; author reply e21
31. Bolli, R. (2015) Reflections on the irreproducibility of scientific papers. Circ. Res. 117, 665–666
32. Arumugam, T. V., Magnus, T., Woodruff, T. M., Proctor, L. M., Shiels, I. A., and Taylor, S. M. (2006) Complement mediators in ischemia-reperfusion injury. Clin. Chim. Acta 374, 33–45
33. Halade, G. V., and Ma, Y. (2016) Neutrophils: friend, foe, or contextual ally in myocardial healing. J. Mol. Cell. Cardiol. 97, 44–46
34. Kalogeris, T., Baines, C. P., Krenz, M., and Korthuis, R. J. (2012) Cell biology of ischemia/reperfusion injury. Int. Rev. Cell Mol. Biol. 298, 229–317
35. Epelman, S., and Mann, D. L. (2012) Communication in the heart: the role of the innate immune system in coordinating cellular responses to ischemic injury. J. Cardiovasc. Transl. Res. 5, 827–836
36. Jung, K., Kim, P., Leuschner, F., Gorbatov, R., Kim, J. K., Ueno, T., Nahrendorf, M., and Yun, S. H. (2013) Endoscopic time-lapse imaging of immune cells in infarcted mouse hearts. Circ. Res. 112, 891–899
37. Nahrendorf, M., Swirski, F. K., Aikawa, E., Stangenberg, L., Wurdinger, T., Figueiredo, J.-L., Libby, P., Weissleder, R., and Pittet, M. J. (2007) The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J. Exp. Med. 204, 3037–3047
38. Dewald, O., Zymek, P., Winkelmann, K., Koerting, A., Ren, G., Abou-Khamis, T., Michael, L. H., Rollins, B. J., Entman, M. L., and Frangogiannis, N. G. (2005) CCL2/monocyte chemoattractant protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circ. Res. 96, 881–889
39. Glezeva, N., Horgan, S., and Baugh, J. A. (2015) Monocyte and macrophage subsets along the continuum to heart failure: misguided heroes or targetable villains? J. Mol. Cell. Cardiol. 89 (Pt B), 136–145
40. Gordon, S., and Taylor, P. R. (2005) Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5, 953–964
41. Mantovani, A., Sozzani, S., Locati, M., Allavena, P., and Sica, A. (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23, 549–555
42. Porcheray, F., Viaud, S., Rimaniol, A.-C., Léone, C., Samah, B., Dereuddre-Bosquet, N., Dormont, D., and Gras, G. (2005) Macrophage activation switching: an asset for the resolution of inflammation. Clin. Exp. Immunol. 142, 481–489
43. Pechkovsky, D. V., Prasse, A., Kollert, F., Engel, K. M., Dentler, J., Luttmann, W., Friedrich, K., Müller-Quernheim, J., and Zissel, G. (2010) Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transduction. Clin. Immunol. 137, 89–101
44. Li, K., Xu, W., Guo, Q., Jiang, Z., Wang, P., Yue, Y., and Xiong, S. (2009) Differential macrophage polarization in male and female BALB/c mice infected with coxsackievirus B3 defines susceptibility to viral myocarditis. Circ. Res. 105, 353–364
45. Aurora, A. B., Porrello, E. R., Tan, W., Mahmoud, A. I., Hill, J. A., Bassel-Duby, R., Sadek, H. A., and Olson, E. N. (2014) Macrophages are required for neonatal heart regeneration. J. Clin. Invest. 124, 1382–1392
46. Frantz, S., and Nahrendorf, M. (2014) Cardiac macrophages and their role in ischaemic heart disease. Cardiovasc. Res. 102, 240–248
47. Van der Laan, A. M., Ter Horst, E. N., Delewi, R., Begieneman, M. P., Krijnen, P. A., Hirsch, A., Lavaei, M., Nahrendorf, M., Horrevoets, A. J., Niessen, H. W., and Piek, J. J. (2014) Monocyte subset accumulation in the human heart following acute myocardial infarction and the role of the spleen as monocyte reservoir. Eur. Heart J. 35, 376–385
48. Tsujioka, H., Imanishi, T., Ikejima, H., Kuroi, A., Takarada, S., Tanimoto, T., Kitabata, H., Okochi, K., Arita, Y., Ishibashi, K., Komukai, K., Kataiwa, H., Nakamura, N., Hirata, K., Tanaka, A., and Akasaka, T. (2009) Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction. J. Am. Coll. Cardiol. 54, 130–138
49. Italiani, P., and Boraschi, D. (2014) From monocytes to M1/M2 macrophages: phenotypical vs. functional differentiation. Front. Immunol. 5, 514
50. Arnold, L., Henry, A., Poron, F., Baba-Amer, Y., van Rooijen, N., Plonquet, A., Gherardi, R. K., and Chazaud, B. (2007) Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J. Exp. Med. 204, 1057–1069
51. Alibhai, F. J., Tsimakouridze, E. V., Chinnappareddy, N., Wright, D. C., Billia, F., O’Sullivan, M. L., Pyle, W. G., Sole, M. J., and Martino, T. A. (2014) Short-term disruption of diurnal rhythms after murine myocardial infarction adversely affects long-term myocardial structure and function. Circ. Res. 114, 1713–1722
52. Halade, G. V., El Jamali, A., Williams, P. J., Fajardo, R. J., and Fernandes, G. (2011) Obesity-mediated inflammatory microenvironment stimulates osteoclastogenesis and bone loss in mice. Exp. Gerontol. 46, 43–52
53. Reiter, R., Swingen, C., Moore, L., Henry, T. D., and Traverse, J. H. (2012) Circadian dependence of infarct size and left ventricular function after ST elevation myocardial infarction. Circ. Res. 110, 105–110
54. Troidl, C., Möllmann, H., Nef, H., Masseli, F., Voss, S., Szardien, S., Willmer, M., Rolf, A., Rixe, J., Troidl, K., Kostin, S., Hamm, C., and Elsässer, A. (2009) Classically and alternatively activated macrophages contribute to tissue remodelling after myocardial infarction. J. Cell. Mol. Med. 13 (9B), 3485–3496
55. Saxena, A., Chen, W., Su, Y., Rai, V., Uche, O. U., Li, N., and Frangogiannis, N. G. (2013) IL-1 induces proinflammatory leukocyte infiltration and regulates fibroblast phenotype in the infarcted myocardium. J. Immunol. 191, 4838–4848
56. Nahrendorf, M., Pittet, M. J., and Swirski, F. K. (2010) Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. Circulation 121, 2437–2445
57. Yan, X., Anzai, A., Katsumata, Y., Matsuhashi, T., Ito, K., Endo, J., Yamamoto, T., Takeshima, A., Shinmura, K., Shen, W., Fukuda, K., and Sano, M. (2013) Temporal dynamics of cardiac immune cell accumulation following acute myocardial infarction. J. Mol. Cell. Cardiol. 62, 24–35
58. Chow, A., Huggins, M., Ahmed, J., Hashimoto, D., Lucas, D., Kunisaki, Y., Pinho, S., Leboeuf, M., Noizat, C., van Rooijen, N., Tanaka, M., Zhao, Z. J., Bergman, A., Merad, M., and Frenette, P. S. (2013) CD169+ macrophages provide a niche promoting erythropoiesis under homeostasis and stress. Nat. Med. 19, 429–436
59. Ehninger, A., and Trumpp, A. (2011) The bone marrow stem cell niche grows up: mesenchymal stem cells and macrophages move in. J. Exp. Med. 208, 421–428
60. Lo Celso, C., and Scadden, D. T. (2011) The haematopoietic stem cell niche at a glance. J. Cell Sci. 124, 3529–3535
61. Haubner, B. J., Schneider, J., Schweigmann, U., Schuetz, T., Dichtl, W., Velik-Salchner, C., Stein, J.-I., and Penninger, J. M. (2016) Functional recovery of a human neonatal heart after severe myocardial infarction. Circ. Res. 118, 216–221
62. Assmus, B., Iwasaki, M., Schächinger, V., Roexe, T., Koyanagi, M., Iekushi, K., Xu, Q., Tonn, T., Seifried, E., Liebner, S., Kranert, W. T., Grünwald, F., Dimmeler, S., and Zeiher, A. M. (2012) Acute myocardial infarction activates progenitor cells and increases Wnt signalling in the bone marrow. Eur. Heart J. 33, 1911–1919
63. Massa, M., Rosti, V., Ferrario, M., Campanelli, R., Ramajoli, I., Rosso, R., De Ferrari, G. M., Ferlini, M., Goffredo, L., Bertoletti, A., Klersy, C., Pecci, A., Moratti, R., and Tavazzi, L. (2005) Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 105, 199–206
64. Núñez, J., Núñez, E., Bodí, V., Sanchis, J., Miñana, G., Mainar, L., Santas, E., Merlos, P., Rumiz, E., Darmofal, H., Heatta, A. M., and Llàcer, A. (2008) Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction. Am. J. Cardiol. 101, 747–752
65. Zouggari, Y., Ait-Oufella, H., Bonnin, P., Simon, T., Sage, A. P., Guérin, C., Vilar, J., Caligiuri, G., Tsiantoulas, D., Laurans, L., Dumeau, E., Kotti, S., Bruneval, P., Charo, I. F., Binder, C. J., Danchin, N., Tedgui, A., Tedder, T. F., Silvestre, J.-S., and Mallat, Z. (2013) B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction. Nat. Med. 19, 1273–1280
66. Hofmann, U., Beyersdorf, N., Weirather, J., Podolskaya, A., Bauersachs, J., Ertl, G., Kerkau, T., and Frantz, S. (2012) Activation of CD4+ T lymphocytes improves wound healing and survival after experimental myocardial infarction in mice. Circulation 125, 1652–1663
67. Liu, L.-L., Lu, J.-L., Chao, P.-L., Lin, L.-R., Zhang, Z.-Y., and Yang, T.-C. (2011) Lower prevalence of circulating invariant natural killer T (iNKT) cells in patients with acute myocardial infarction undergoing primary coronary stenting. Int. Immunopharmacol. 11, 480–484
68. Yan, W., Zhou, L., Wen, S., Duan, Q., Huang, F., Tang, Y., Liu, X., Chai, Y., and Wang, L. (2015) Differential loss of natural killer cell activity in patients with acute myocardial infarction and stable angina pectoris. Int. J. Clin. Exp. Pathol. 8, 14667–14675
69. Al-Ahmad, R. S., Mahafzah, A. M., and Al-Mousa, E. N. (2004) Immunological changes in acute myocardial infarction. Saudi Med. J. 25, 923–928
70. Blum, A., and Yeganeh, S. (2003) The role of T-lymphocyte subpopulations in acute myocardial infarction. Eur. J. Intern. Med. 14, 407–410
71. Fang, L., Moore, X.-L., Dart, A. M., and Wang, L.-M. (2015) Systemic inflammatory response following acute myocardial infarction. J. Geriatr. Cardiol. 12, 305–312
72. Backteman, K., Ernerudh, J., and Jonasson, L. (2014) Natural killer (NK) cell deficit in coronary artery disease: no aberrations in phenotype but sustained reduction of NK cells is associated with low-grade inflammation. Clin. Exp. Immunol. 175, 104–112
73. Hofmann, U., and Frantz, S. (2015) Role of lymphocytes in myocardial injury, healing, and remodeling after myocardial infarction. Circ. Res. 116, 354–367
74. Dobaczewski, M., Xia, Y., Bujak, M., Gonzalez-Quesada, C., and Frangogiannis, N. G. (2010) CCR5 signaling suppresses inflammation and reduces adverse remodeling of the infarcted heart, mediating recruitment of regulatory T cells. Am. J. Pathol. 176, 2177–2187
75. Linfert, D., Chowdhry, T., and Rabb, H. (2009) Lymphocytes and ischemia-reperfusion injury. Transplant. Rev. (Orlando) 23, 1–10
76. Martin, F., and Chan, A. C. (2006) B cell immunobiology in disease: evolving concepts from the clinic. Annu. Rev. Immunol. 24, 467–496
77. Kim, N. D., and Luster, A. D. (2013) To B or not to B–that is the question for myocardial infarction. Nat. Med. 19, 1208–1210
78. Yanaba, K., Bouaziz, J.-D., Matsushita, T., Magro, C. M., St Clair, E. W., and Tedder, T. F. (2008) B-lymphocyte contributions to human autoimmune disease. Immunol. Rev. 223, 284–299
79. Tsiantoulas, D., Sage, A. P., Mallat, Z., and Binder, C. J. (2015) Targeting B cells in atherosclerosis: closing the gap from bench to bedside. Arterioscler. Thromb. Vasc. Biol. 35, 296–302
80. Silverman, H. S., and Pfeifer, M. P. (1987) Relation between use of anti-inflammatory agents and left ventricular free wall rupture during acute myocardial infarction. Am. J. Cardiol. 59, 363–364
81. Nathan, C., and Ding, A. (2010) Nonresolving inflammation. Cell 140, 871–882
82. Serhan, C. N., Chiang, N., and Van Dyke, T. E. (2008) Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 8, 349–361
83. Serhan, C. N. (2014) Pro-resolving lipid mediators are leads for resolution physiology. Nature 510, 92–101
84. Serhan, C. N. (2010) Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not? Am. J. Pathol. 177, 1576–1591
85. Keyes, K. T., Ye, Y., Lin, Y., Zhang, C., Perez-Polo, J. R., Gjorstrup, P., and Birnbaum, Y. (2010) Resolvin E1 protects the rat heart against reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 299, H153–H164
86. Arita, M., Ohira, T., Sun, Y.-P., Elangovan, S., Chiang, N., and Serhan, C. N. (2007) Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. J. Immunol. 178, 3912–3917
87. Kain, V., Ingle, K. A., Colas, R. A., Dalli, J., Prabhu, S. D., Serhan, C. N., Joshi, M., and Halade, G. V. (2015) Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function. J. Mol. Cell. Cardiol. 84, 24–35
88. Lavine, K. J., Epelman, S., Uchida, K., Weber, K. J., Nichols, C. G., Schilling, J. D., Ornitz, D. M., Randolph, G. J., and Mann, D. L. (2014) Distinct macrophage lineages contribute to disparate patterns of cardiac recovery and remodeling in the neonatal and adult heart. Proc. Natl. Acad. Sci. USA 111, 16029–16034Z
89. Kaikita, K., Hayasaki, T., Okuma, T., Kuziel, W. A., Ogawa, H., and Takeya, M. (2004) Targeted deletion of CC chemokine receptor 2 attenuates left ventricular remodeling after experimental myocardial infarction. Am. J. Pathol. 165, 439–447
90. Fujiu, K., Wang, J., and Nagai, R. (2014) Cardioprotective function of cardiac macrophages. Cardiovasc. Res. 102, 232–239
91. Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y., and Henson, P. M. (1998) Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest. 101, 890–898
92. Schif-Zuck, S., Gross, N., Assi, S., Rostoker, R., Serhan, C. N., and Ariel, A. (2011) Saturated-efferocytosis generates pro-resolving CD11b low macrophages: modulation by resolvins and glucocorticoids. Eur. J. Immunol. 41, 366–379
93. Moore, K. J., El Khoury, J., Medeiros, L. A., Terada, K., Geula, C., Luster, A. D., and Freeman, M. W. A. (2002) A CD36-initiated signaling cascade mediates inflammatory effects of beta-amyloid. J. Biol. Chem. 277, 47373–47379
94. Rohlmann, A., Gotthardt, M., Hammer, R. E., and Herz, J. (1998) Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants. J. Clin. Invest. 101, 689–695
95. Camenisch, T. D., Koller, B. H., Earp, H. S., and Matsushima, G. K. (1999) A novel receptor tyrosine kinase, Mer, inhibits TNF-alpha production and lipopolysaccharide-induced endotoxic shock. J. Immunol. 162, 3498–3503
96. Wan, E., Yeap, X. Y., Dehn, S., Terry, R., Novak, M., Zhang, S., Iwata, S., Han, X., Homma, S., Drosatos, K., Lomasney, J., Engman, D. M., Miller, S. D., Vaughan, D. E., Morrow, J. P., Kishore, R., and Thorp, E. B. (2013) Enhanced efferocytosis of apoptotic cardiomyocytes through myeloid-epithelial-reproductive tyrosine kinase links acute inflammation resolution to cardiac repair after infarction. Circ. Res. 113, 1004–1012
97. O’Neill, L. A. J. (2008) When signaling pathways collide: positive and negative regulation of Toll-like receptor signal transduction. Immunity 29, 12–20
98. Micera, A., Balzamino, B. O., Di Zazzo, A., Biamonte, F., Sica, G., and Bonini, S. (2016) Toll-like receptors and tissue remodeling: the pro/ cons recent findings. J. Cell. Physiol. 231, 531–544
99. Pepys, M. B., Hirschfield, G. M., Tennent, G. A., Gallimore, J. R., Kahan, M. C., Bellotti, V., Hawkins, P. N., Myers, R. M., Smith, M. D., Polara, A., Cobb, A. J. A., Ley, S. V., Aquilina, J. A., Robinson, C. V., Sharif, I., Gray, G. A., Sabin, C. A., Jenvey, M. C., Kolstoe, S. E., Thompson, D., and Wood, S. P. (2006) Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 440, 1217–1221
100. Salio, M., Chimenti, S., De Angelis, N., Molla, F., Maina, V., Nebuloni, M., Pasqualini, F., Latini, R., Garlanda, C., and Mantovani, A. (2008) Cardioprotective function of the long pentraxin PTX3 in acute myocardial infarction. Circulation 117, 1055–1064
101. Suzuki, K., Murtuza, B., Smolenski, R. T., Sammut, I. A., Suzuki, N., Kaneda, Y., and Yacoub, M. H. (2001) Overexpression of interleukin-1 receptor antagonist provides cardioprotection against ischemia-reperfusion injury associated with reduction in apoptosis. Circulation 104 (12 Suppl 1), I-308–I-313
102. Thorp, E., and Tabas, I. (2009) Mechanisms and consequences of efferocytosis in advanced atherosclerosis. J. Leukoc. Biol. 86, 1089–1095
103. Tabas, I. (2010) Macrophage death and defective inflammation resolution in atherosclerosis. Nat. Rev. Immunol. 10, 36–46
104. Henson, P. M., Bratton, D. L., and Fadok, V. A. (2001) Apoptotic cell removal. Curr. Biol. 11, R795–R805
105. Wilensky, R. L., and Macphee, C. H. (2009) Lipoprotein-associated phospholipase A2 and atherosclerosis. Curr. Opin. Lipidol. 20, 415–420
106. Sather, S., Kenyon, K. D., Lefkowitz, J. B., Liang, X., Varnum, B. C., Henson, P. M., and Graham, D. K. (2007) A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregation. Blood 109, 1026–1033
107. Li, S., Sun, Y., Liang, C.-P., Thorp, E. B., Han, S., Jehle, A. W., Saraswathi, V., Pridgen, B., Kanter, J. E., Li, R., Welch, C. L., Hasty, A. H., Bornfeldt, K. E., Breslow, J. L., Tabas, I., and Tall, A. R. (2009) Defective phagocytosis of apoptotic cells by macrophages in atherosclerotic lesions of ob/ob mice and reversal by a fish oil diet. Circ. Res. 105, 1072–1082
108. Kreisel, D., Nava, R. G., Li, W., Zinselmeyer, B. H., Wang, B., Lai, J., Pless, R., Gelman, A. E., Krupnick, A. S., and Miller, M. J. (2010) In vivo two-photon imaging reveals monocyte-dependent neutrophil extravasation during pulmonary inflammation. Proc. Natl. Acad. Sci. USA 107, 18073–18078
109. Liu, S., and Trapnell, C. (2016) Single-cell transcriptome sequencing: recent advances and remaining challenges. F1000 Res. 5, F1000 Faculty Rev-182
110. Carr, E. J., Dooley, J., Garcia-Perez, J. E., Lagou, V., Lee, J. C., Wouters, C., Meyts, I., Goris, A., Boeckxstaens, G., Linterman, M. A., and Liston, A. (2016) The cellular composition of the human immune system is shaped by age and cohabitation. Nat. Immunol. 17, 461–468
111. De Jager, P. L., Hacohen, N., Mathis, D., Regev, A., Stranger, B. E., and Benoist, C. (2015) ImmVar project: insights and design considerations for future studies of “healthy” immune variation. Semin. Immunol. 27, 51–57
112. Brodin, P., Jojic, V., Gao, T., Bhattacharya, S., Angel, C. J. L., Furman, D., Shen-Orr, S., Dekker, C. L., Swan, G. E., Butte, A. J., Maecker, H. T., and Davis, M. M. (2015) Variation in the human immune system is largely driven by non-heritable influences. Cell 160, 37–47
113. Hirayasu, K., and Arase, H. (2015) Functional and genetic diversity of leukocyte immunoglobulin-like receptor and implication for disease associations. J. Hum. Genet. 60, 703–708
114. Vieira Braga, F. A., Teichmann, S. A., and Chen, X. (2016) Genetics and immunity in the era of single-cell genomics. Hum. Mol. Genet. 25 (R2), R141–R148
115. Swirski, F. K., Nahrendorf, M., Etzrodt, M., Wildgruber, M., Cortez-Retamozo, V., Panizzi, P., Figueiredo, J.-L., Kohler, R. H., Chudnovskiy, A., Waterman, P., Aikawa, E., Mempel, T. R., Libby, P., Weissleder, R., and Pittet, M. J. (2009) Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 325, 612–616
116. Halade, G. V., Kain, V., Black, L. M., Prabhu, S. D., and Ingle, K. A. (2016) Aging dysregulates D- and E-series resolvins to modulate cardiosplenic and cardiorenal network following myocardial infarction. Aging (Albany NY) 8, 2611–2634
117. Leuschner, F., Rauch, P. J., Ueno, T., Gorbatov, R., Marinelli, B., Lee, W. W., Dutta, P., Wei, Y., Robbins, C., Iwamoto, Y., Sena, B., Chudnovskiy, A., Panizzi, P., Keliher, E., Higgins, J. M., Libby, P., Moskowitz, M. A., Pittet, M. J., Swirski, F. K., Weissleder, R., and Nahrendorf, M. (2012) Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis. J. Exp. Med. 209, 123–137
118. Ismahil, M. A., Hamid, T., Bansal, S. S., Patel, B., Kingery, J. R., and Prabhu, S. D. (2014) Remodeling of the mononuclear phagocyte network underlies chronic inflammation and disease progression in heart failure: critical importance of the cardiosplenic axis. Circ. Res. 114, 266–282
119. Shaw, A. C., Goldstein, D. R., and Montgomery, R. R. (2013) Age-dependent dysregulation of innate immunity. Nat. Rev. Immunol. 13, 875–887
120. Franceschi, C., Bonafè, M., Valensin, S., Olivieri, F., De Luca, M., Ottaviani, E., and De Benedictis, G. (2000) Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci. 908, 244–254
121. Funk, C. D., and FitzGerald, G. A. (2007) COX-2 inhibitors and cardiovascular risk. J. Cardiovasc. Pharmacol. 50, 470–479
122. Baylis, D., Bartlett, D. B., Patel, H. P., and Roberts, H. C. (2013) Understanding how we age: insights into inflammaging. Longev. Healthspan. 2, 8
123. Fuijkschot, W. W, Groothuizen, W. E., Appelman Y., Radonic, T., van Royen, N., van Leeuwen, M. A., Krijnen, P. A., van der Wal, A. C., Smulders, Y. M., and Niessen, H. W. (2017) Inflammatory cell content of coronary thrombi is dependent on thrombus age in patients with ST-elevation myocardial infarction. J. Cardiol. 69, 394–400
124. Frangogiannis, N. G., Mendoza, L. H., Ren, G., Akrivakis, S., Jackson, P. L., Michael, L. H., Smith, C. W., and Entman, M. L. (2003) MCSF expression is induced in healing myocardial infarcts and may regulate monocyte and endothelial cell phenotype. Am. J. Physiol. Heart Circ. Physiol. 285, H483–H492
125. Frantz, S., Hofmann, U., Fraccarollo, D., Schäfer, A., Kranepuhl, S., Hagedorn, I., Nieswandt, B., Nahrendorf, M., Wagner, H., Bayer, B., Pachel, C., Schön, M. P., Kneitz, S., Bobinger, T., Weidemann, F., Ertl, G., and Bauersachs, J. (2013) Monocytes/ macrophages prevent healing defects and left ventricular thrombus formation after myocardial infarction. FASEB J. 27, 871–881
126. Fan, K., Ruan, Q., Sensenbrenner, L., and Chen, B. (1992) Transforming growth factor-beta 1 bifunctionally regulates murine macrophage proliferation. Blood 79, 1679–1685
127. Kehrl, J. H., Wakefield, L. M., Roberts, A. B., Jakowlew, S., Alvarez-Mon, M., Derynck, R., Sporn, M. B., and Fauci, A. S. (1986) Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 163, 1037–1050
128. Yoshimura, A., Wakabayashi, Y., and Mori, T. (2010) Cellular and molecular basis for the regulation of inflammation by TGF-beta. J. Biochem. 147, 781–792
129. Wahl, S. M., Hunt, D. A., Wakefield, L. M., McCartney-Francis, N., Wahl, L. M., Roberts, A. B., and Sporn, M. B. (1987) Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc. Natl. Acad. Sci. USA 84, 5788–5792
130. Letterio, J. J., and Roberts, A. B. (1998) Regulation of immune responses by TGF-beta. Annu. Rev. Immunol. 16, 137–161
131. Werner, F., Jain, M. K., Feinberg, M. W., Sibinga, N. E., Pellacani, A., Wiesel, P., Chin, M. T., Topper, J. N., Perrella, M. A., and Lee, M. E. (2000) Transforming growth factor-beta 1 inhibition of macrophage activation is mediated via Smad3. J. Biol. Chem. 275, 36653–36658
132. Saxena, A., Russo, I., and Frangogiannis, N. G. (2016) Inflammation as a therapeutic target in myocardial infarction: learning from past failures to meet future challenges. Transl. Res. 167, 152–166
133. Saito, T., Rodger, I. W., Hu, F., Robinson, R., Huynh, T., and Giaid, A. (2004) Inhibition of COX pathway in experimental myocardial infarction. J. Mol. Cell. Cardiol. 37, 71–77
134. Kimmel, S. E., Berlin, J. A., Reilly, M., Jaskowiak, J., Kishel, L., Chittams, J., and Strom, B. L. (2005) Patients exposed to rofecoxib and celecoxib have different odds of nonfatal myocardial infarction. Ann. Intern. Med. 142, 157–164
135. Mann, D. L., McMurray, J. J. V., Packer, M., Swedberg, K., Borer, J. S., Colucci, W. S., Djian, J., Drexler, H., Feldman, A., Kober, L., Krum, H., Liu, P., Nieminen, M., Tavazzi, L., van Veldhuisen, D. J., Waldenstrom, A., Warren, M., Westheim, A., Zannad, F., and Fleming, T. (2004) Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation 109, 1594–1602
136. Steg, P. G., James, S. K., Atar, D., Badano, L. P., Blömstrom-Lundqvist, C., Borger, M. A., Di Mario, C., Dickstein, K., Ducrocq, G., Fernandez-Aviles, F., Gershlick, A. H., Giannuzzi, P., Halvorsen, S., Huber, K., Juni, P., Kastrati, A., Knuuti, J., Lenzen, M. J., Mahaffey, K. W., Valgimigli, M., van’t Hof, A., Widimsky, P., and Zahger, D.; Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology (ESC). (2012) ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur. Heart J. 33, 2569–2619
137. Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Jr., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., Johnson, M. R., Kasper, E. K., Levy, W. C., Masoudi, F. A., McBride, P. E., McMurray, J. J., Mitchell, J. E., Peterson, P. N., Riegel, B., Sam, F., Stevenson, L. W., Tang, W. H., Tsai, E. J., and Wilkoff, B. L.; Writing Committee members, American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013) 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 128, e240–e327
138. Epelman, S., Lavine, K. J., Beaudin, A. E., Sojka, D. K., Carrero, J. A., Calderon, B., Brija, T., Gautier, E. L., Ivanov, S., Satpathy, A. T., Schilling, J. D., Schwendener, R., Sergin, I., Razani, B., Forsberg, E. C., Yokoyama, W. M., Unanue, E. R., Colonna, M., Randolph, G. J., and Mann, D. L. (2014) Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation. Immunity 40, 91–104
139. Gong, K., Zhang, Z., Sun, X., Zhang, X., Li, A., Yan, J., Luo, Q., Gao, Y., and Feng, Y. (2006) The nonspecific anti-inflammatory therapy with methotrexate for patients with chronic heart failure. Am. Heart J. 151, 62–68
140. Ramasubbu, K., Estep, J., White, D. L., Deswal, A., and Mann, D. L. (2008) Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopathy. J. Am. Coll. Cardiol. 51, 415–426
141. McMurray, J. J. V., Kjekshus, J., Gullestad, L., Dunselman, P., Hjalmarson, A., Wedel, H., Lindberg, M., Waagstein, F., Grande, P., Hradec, J., Kamenský, G., Korewicki, J., Kuusi, T., Mach, F., Ranjith, N., and Wikstrand, J.; CORONA Study Group. (2009) Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysis. Circulation 120, 2188–2196